Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques
Open accessThe DOI matches its Crossref record; 104 of the 105 references it cites were found in a registry or an index, and 1 are not checked yet; 68 of the 129 sources its claims cite were checked for support.
Abstract
Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is one of the most technically challenging monogenic conditions for molecular diagnosis, owing to the complex genomic architecture of the CYP21A2 locus and the extensive homology between the functional gene and its pseudogene. Over the past decades, diagnostic approaches have evolved from locus-specific assays, such as allele-specific polymerase chain reaction, to the combined use of Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA), which together constituted the historical gold-standard approach strategy capable of identifying pathogenic variants, deletions and chimeric alleles. Although short-read next-generation sequencing expanded variant detection and enabled simultaneous analysis of multiple adrenal genes, its performance remains limited within the RCCX region due to misalignment artefacts and inability to resolve complex structural rearrangements. Recently, long-read sequencing (LRS) has emerged as a single-platform technology capable of resolving the CYP21A2–CYP21A1P module, accurately detecting all variant classes and directly determining cis/trans phase.
Verified 2026-10-10 · 1 reference not checked yet
Overview
CoChat Summary
## TL;DR
This is a review of how molecular diagnosis of 21-hydroxylase deficiency (21-OHD) evolved from targeted, labor-intensive assays to Sanger/MLPA, short-read NGS, and now long-read sequencing. The paper argues that long-read sequencing is emerging as the best single-platform solution for the highly complex CYP21A2 locus, with studies reporting 100% sensitivity and specificity and improved genotype assignment in 14.6% of cases.
## Key findings
- 21-OHD accounts for approximately 90–95% of CAH cases, and the disorder affects about 1:13,000 to 1:15,000 live births.
- The review states that 90–95% of pathogenic CYP21A2 variants arise from intergenic recombination with the pseudogene; 70–75% are microconversion events and 20–25% are due to unequal meiotic crossover, while only 5–10% of small pathogenic variants occur independently of gene conversion.
- Classical Sanger plus MLPA detects nearly all pathogenic alleles in most populations, with the text stating coverage of up to 98–99% of classical pathogenic alleles.
- Long-read sequencing studies reported in the paper found 100% sensitivity and specificity in one workflow, and in a cohort of 322 probands it improved precise genotype assignment in 14.6% of cases.
## Methods
- Narrative review synthesizing historical, technical, and clinical literature on molecular diagnosis of 21-OHD, focusing on CYP21A2 and the RCCX locus.
- Compares diagnostic strategies across four broad classes: Southern blot/MLPA, targeted genotyping, Sanger sequencing, short-read NGS, and long-read sequencing.
- Uses published studies and cohort reports to summarize analytical performance, genotype-phenotype correlation, and clinical implications for newborn screening and counseling.
## Limitations
- The paper is a review and does not present a new primary dataset; this is evident from the text.
- It states that reported functional activity values and genotype-phenotype concordance rates vary across studies because of heterogeneous experimental systems and populations; this is a limitation stated in the paper.
- The text makes evident that evidence for long-read sequencing is still based on selected studies and implementation remains limited by DNA quality, cost, computational resources, and lack of routine standardization; these are stated as current constraints in the paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Locus RCCX: Schematic representation of the RCCX locus within the MHC region on chromosome 6p21.3, showing the modular arrangement RP–C4–CYP21A1P/CYP21A2–TNX. The functional CYP21A2 gene resides adjacent to its highly homologous pseudogene CYP21A1P, while flanking TNXA/TNXB genes predispose this region to non-allelic homologous recombination, leading to gene conversions, deletions, and chimeric alleles associated with congenital adrenal hyperplasia. Major CYP21A2 pathogenic variants derived from the CYP21A1P pseudogene across the exonic structure of CYP21A2: Schematic representation of the ten exons of the CYP21A2 gene indicating the location of the most frequent pseudogene-derived pathogenic variants associated with 21-hydroxylase deficiency, including p.(Pro31Leu), p.(Gly111fs), c.293-13C>G, p.(Ile173Asn), exon 6 cluster (p.[Ile237Asn], p.[Val238Glu], p.[Met240Lys]), p.(Val282Leu), p.(Leu308fs), p.(Gln319Ter), p.(Arg357Trp), and p.(Pro454Ser). These variants arise predominantly through microconversion events from CYP21A1P and represent the majority of disease-causing alleles worldwide. Adapted from Concolino et al (16). This schematic representation is not drawn to scale. Exon sizes, intergenic distances, and relative gene lengths are depicted for illustrative purposes only. Arrows indicate regions of gene conversion or recombination events within the RCCX locus and do not represent physical distances.](https://figures.cochat.ai/paper-figures/b6ded6d530f646b59512c45565931d81/evolution-of-molecular-diagnostic-strategies-for-21-hydroxylase-deficiency-from-figure-1.jpg)

Verification
Claims the paper makes
44 Valid · 3 Not valid · 15 Not checked · 19 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is one of the most technically challenging monogenic conditions for molecular diagnosis, owing to the complex genomic architecture of the CYP21A2 locus and the extensive homology between the functional gene and its pseudogene.”
- Also stated in: § Introduction · plain
“This milestone revealed the presence of a highly homologous pseudogene, CYP21A1P, located within the complex RCCX module, an insight that helped explain the high frequency of recombination events underlying the disorder (9, 10).”
§ Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques > Abstract Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is one of the most technically challenging monogenic conditions for molecular diagnosis, owing to the complex genomic architecture of the CYP21A2 locus and the extensive homology between the functional gene and its pseudogene. Over the past decades, diagnostic approaches have evolved from locus-specific assays, such as allele-specific polymerase chain reaction, to the combined use of Sanger sequencing and multiplex ligation-dependent probe amplification (MLPA), which together constituted the historical gold-standard approach strategy capable of identifying pathogenic variants, deletions and chimeric alleles. Although short-read next-generation sequencing expanded variant detection and enabled simultaneous analysis of multiple adrenal genes, its performance remains limited within the RCCX region due to misalignment artefacts and inability to resolve complex structural rearrangements. Recently, long-read sequencing (LRS) has emerged as a single-platform technology capable of resolving the CYP21A2–CYP21A1P module, accurately detecting all variant classes and directly determining cis/trans phase. Comparative studies demonstrated complete concordance with standard methods while revealing additional rearrangements previously undetectable, positioning LRS as a future reference method for high-resolution genotyping. These advances extend beyond diagnostic refinement to impact population-level strategies, where integration of molecular testing into newborn screening algorithms reduces false positives, accelerates referral pathways, and enhances salt-wasting risk prediction. In this review, we summarized the historical development, technical limitations, and clinical implications of current and emerging molecular approaches for CAH diagnosis. We highlight how LRS and integrative analytical tools are reshaping clinical practice, refining genetic counselling, and guiding personalized therapeutic strategies. Collectively, these innovations represent a decisive step toward precision Endocrinology.
What the sources say
- Partly supportedcites [9] White, 1986, Structure of human steroid 21-hydroxylase genes, Proc Natl Acad Sci sourceExperimental — accuracy not yet measured
The paper’s Abstract identifies an active 21-hydroxylase B gene and an A pseudogene, and its gene-structure section reports 98% exon and 96% intron homology between them (page not available in our copy). These findings support the claimed genomic architecture and extensive homology. The paper does not characterize molecular diagnosis of this condition as one of the most technically challenging among monogenic conditions. (LLM, conf=0.86)
- Partly supportedcites [10] Higashi, 1986, Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and a genuine gene, Proc Natl Acad Sci sourceExperimental — accuracy not yet measured
The introduction describes two closely linked 21-hydroxylase genes, and Results and Discussion identifies one as a pseudogene and reports 98% sequence homology between them. These passages support the claim about the locus’s architecture and gene–pseudogene homology, but they do not assess the technical difficulty of molecular diagnosis or rank it among monogenic conditions. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The remaining 20–25% are attributable to unequal meiotic crossovers, giving rise to extensive genomic rearrangements, including large deletions, duplications, and the formation of chimeric CYP21A1P/CYP21A2 genes.”
§ Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques > Genetic background of the CYP21A2 gene and CAH due 21-OH deficiency
What the sources say
- Not checked — no full text of the sourcecites [5] White, 2000, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*, Endocr Rev source
- Supportedcites [16] Concolino, 2025, Genetics in congenital adrenal hyperplasia due to 21-hydroxylase deficiency and clinical implications, J Endocr Soc source
The Disease-Causing Variants section attributes 20%–25% of the remaining intergenic recombinations to nonuniform meiotic crossing-over. It identifies deletions, duplications, and CYP21A1P/CYP21A2 chimeric genes as consequences of these events. (LLM, conf=0.88)
- Partly supportedcites [19] Yang, 2025, Genetics and pathophysiology of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
In “Molecular Genetics of CAH” (page unavailable), the paper says unequal meiotic crossing-over generates deletions accounting for approximately 20% of mutant alleles, and describes chimeric CYP21A1P/CYP21A2 genes. It does not give a 20–25% range for these rearrangements; it assigns that range to a splice mutation in “Genotype-phenotype Correlation.” Its figure also says the chromosome with three CYP21 copies produced by crossing-over is not associated with disease, so duplications are not supported as pathogenic variants here. (LLM, conf=0.88)
- Partly supportedcites [20] Mello, 2002, Bases moleculares da hiperplasia adrenal congênita, Arq Bras Endocrinol Metabol sourceExperimental — accuracy not yet measured
The mechanism is well supported: our copy (RESUMO) states that unequal pairing/crossing-over of the homologous chromosomes during meiosis produces one allele with duplication of the C4B-CYP21 unit and one with loss of it, and that the resulting deletion allele is a hybrid ('alelo resultante é um híbrido' with 5' CYP21P sequence and 3' CYP21 sequence) — i.e., the chimeric CYP21A1P/CYP21A2 gene. However, the specific magnitude 'the remaining 20–25%' is not stated: the paper gives separate frequencies — deletions estimated at 25% of alleles in salt-wasting forms in Caucasian/West European populations (and only 4–7% in two Brazilian studies) and gene conversions of 10–15% (17% classic-form Brazilian, 7% across all three forms). Its own residual category is different: large rearrangements plus the nine most frequent point mutations account for 80–85% of Brazilian alleles, with the remaining alleles attributed to novel mutations not present in the pseudogene, not to unequal crossovers. Also, the paper treats C4B/CYP21 pseudogene deletions and duplications found in normal subjects as pre-mutations rather than pathogenic variants, so listing duplications among pathogenic CYP21A2 variants overstates it. (LLM, conf=0.75)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Overall, 90–95% of pathogenic CYP21A2 variants arise from intergenic recombination between the active gene and its pseudogene within the RCCX module.”
§ Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques > Genetic background of the CYP21A2 gene and CAH due 21-OH deficiency
What the sources say
- Partly supportedcites [16] Concolino, 2025, Genetics in congenital adrenal hyperplasia due to 21-hydroxylase deficiency and clinical implications, J Endocr Soc sourceExperimental — accuracy not yet measured
The Disease-Causing Variants section attributes the great majority of deleterious variants to intergenic recombination involving CYP21A2 and its pseudogene, and the Gene Locus Structure section places those genes in the RCCX region. The source gives the overall figure as “over 95%,” however, rather than the claimed 90–95%. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [17] Speiser, 2003, Congenital adrenal hyperplasia, N Engl J Med source
- Not checked — no full text of the sourcecites [18] Bachega, 1998, Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency 1, J Clin Endocrinol Metab source
- Supportedcites [19] Yang, 2025, Genetics and pathophysiology of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab source
The Molecular Genetics of CAH section says over 90% of mutations causing 21-hydroxylase deficiency result from intergenic recombination within the 30 kb tandem repeat. It attributes approximately 20% of mutant alleles to unequal crossing-over and 70–75% of disease-causing CYP21A2 mutations to gene conversion from CYP21A1P, consistent with the cited 90–95% range. The CYP21 Genes and the Surrounding Genetic Region section identifies this repeat as the RCCX module. (LLM, conf=0.92)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Among these, microconversion events, in which one or more deleterious pseudogene-derived variants are transferred into CYP21A2 during meiosis, represent 70–75% of all cases (5, 16, 19, 20).”
§ Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques > Genetic background of the CYP21A2 gene and CAH due 21-OH deficiency
What the sources say
- Not checked — no full text of the sourcecites [5] White, 2000, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*, Endocr Rev source
- Partly supportedcites [16] Concolino, 2025, Genetics in congenital adrenal hyperplasia due to 21-hydroxylase deficiency and clinical implications, J Endocr Soc sourceExperimental — accuracy not yet measured
The Disease-Causing Variants section says microconversions transfer deleterious pseudogene variants into CYP21A2 and represent 70%–75% of intergenic recombination events. It says those events account for over 95% of deleterious variants leading to 21-hydroxylase deficiency, so the stated 70%–75% denominator is not explicitly all cases. The Genetic Background section links recombination in this region to meiosis. (LLM, conf=0.88)
- Partly supportedcites [19] Yang, 2025, Genetics and pathophysiology of classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
The Molecular Genetics of CAH section says that gene conversion transfers deleterious variants from CYP21A1P to CYP21A2 and accounts for approximately 70–75% of disease-causing CYP21A2 mutations. It does not give that percentage for all cases or specifically for microconversion events, and it says conversions may arise through either meiotic or mitotic events, not only during meiosis. (LLM, conf=0.86)
- Not checked yetcites [20] Mello, 2002, Bases moleculares da hiperplasia adrenal congênita, Arq Bras Endocrinol Metabol source
Checked before — its earlier verdict is held back until a new check runs.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In 21-OHD, a strong correlation between genotype and phenotype has been consistently reported across multiple populations (22, 26, 46, 47).”
§ Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques > Genotype-phenotype correlation Many studies have investigated genotype-phenotype correlations in large national and multiethnic cohorts. In 21-OHD, a strong correlation between genotype and phenotype has been consistently reported across multiple populations (22, 26, 46, 47). Functional in vitro studies have allowed classification of CYP21A2 pathogenic variants into four groups based on residual enzymatic activity: group 0 (null, 0%), group A (<2%), group B (3-7%), and group C (20-60%), as summarized in Table 1 (18, 31, 48–50). This functional classification provides a useful framework for associating molecular defects with clinical presentation. Functional classification of CYP21A2 variants is based on enzymatic activity measured in vitro; however, these estimates are derived from heterogeneous experimental systems, including different expression models (e.g., COS-1 or HEK293 cells), assay substrates, and normalization strategies. Consequently, reported activity values may vary across studies, and direct quantitative comparisons between variants should be interpreted cautiously, as they represent approximate functional ranges rather than strictly comparable measurements. In general, severe genotypes leading to SW uniformly showed a strong correlation with clinical phenotypes. Reported concordance rates range from 97-100% in null genotypes and 79-96% in A genotypes associated with the SW form, 53-87% in B genotypes associated with the SV form, and 65-100% in C genotypes with the NC form (19, 26, 31, 35, 47). Most affected individuals are compound heterozygotes, and the clinical outcome is typically determined by the allele that maintains the highest residual enzyme activity. Consequently, the SW form generally results from combinations of two severe alleles (groups 0 or A), whereas the SV form arises in patients homozygous for group B variants, or compound heterozygous of group B variants with groups null or A. The NC phenotype usually manifests in carriers of two mild alleles (group C) or combinations of mild and severe (groups null, A or B) variants (22, 26, 47, 48).
What the sources say
- Not checked — no full text of the sourcecites [22] De Carvalho, 2016, Molecular CYP21A2 diagnosis in 480 Brazilian patients with congenital adrenal hyperplasia before newborn screening introduction, Eur J Endocrinol source
- Supportedcites [26] Finkielstain, 2011, Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, J Clin Endocrinol Metab source
The paper’s Abstract reports that several studies found 80–90% genotype–phenotype concordance in 21-OHD. Its Genotype phenotype correlation section reports accurate phenotype prediction in 85.1–97.8% of patients across four mutation groups, while the Discussion notes exceptions and compares findings from Germany and the Netherlands. (LLM, conf=0.91)
- Supportedcites [46] Bachega, 2004, Estudo multicêntrico de pacientes brasileiros com deficiência da 21-hidroxilase: Correlação do genótipo com o fenótipo, Arq Bras Endocrinol Metabol source
The 'Correlação do Genótipo com o Fenótipo' section states 'Houve uma boa correlação do genótipo com o fenótipo' with group A → classical (salt wasting 77%), group B → simple virilizing (98%) and group C → non-classical (92%) in the 205-patient Brazilian multicentre sample, and explicitly frames this as concordant with other population studies ('de forma semelhante ao observado em outros estudos populacionais (10,15-17)'). The CONCLUSÕES and the English abstract generalise it to 21-hydroxylase deficiency ('The good genotype-phenotype correlation in patients with 21-hydroxylase deficiency shows the usefulness of genotype to predict the clinical form'), with the stated caveat of the I2 splice mutation and a Finnish series (ref. 27) in which group B was also linked to salt wasting. As a broad background statement, the claim matches how our copy treats the topic. (LLM, conf=0.85)
- Partly supportedcites [47] Krone, 2013, Genotype-phenotype correlation in 153 adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Analysis of the United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE) cohort, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
The paper states that a strong genotype–phenotype correlation has been established for salt wasting and impaired adrenomedullary function; its Discussion also finds a similar genotype–salt-loss relationship in children and UK adults. But the Discussion says correlations with genital virilization have been variably reported, and its adult cohort found no association between genotype and most health outcomes. The unqualified claim of a consistently strong correlation across phenotypes is therefore broader than this source supports (page numbers unavailable). (LLM, conf=0.84)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
29 more claims · 15 with their cited sources checked
Create a free account to see all 81 claims and to verify the 4 references still open.
- It may state two separate claims as one. 45
- Probably not a substantial claim. 2
Citations
Cites
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Advancements in Next-Generation Sequencing
Levy, S. E., & Myers, R. M. (2016) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083115-022413 · Cited by 599 · cited 1×
“The NGS assay has increased the diagnosis ef fi cacy for diseases associated with multiple genes (83).”
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Structure of human steroid 21-hydroxylase genes.
White, P. C., New, M. I., & Dupont, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5111 · Cited by 569 · cited 1×
“This milestone revealed the presence of a highly homologous pseudogene, CYP21A1P , located within the complex RCCX module, an insight that helped explain the high frequency of recombination events underlying the disorder (9, 10).”
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556 · cited 3×
“When combined with complementary methods such MLPA for copy number analysis, it provides nearly complete diagnostic coverage, identifying up to 98-99% of classical pathogenic alleles in most populations (1, 16, 76).”
Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., & Fujii-Kuriyama, Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2841 · Cited by 555 · cited 1×
“This milestone revealed the presence of a highly homologous pseudogene, CYP21A1P , located within the complex RCCX module, an insight that helped explain the high frequency of recombination events underlying the disorder (9, 10).”
Cited by
Altıntaş, Z. M., Karaca, S. G., & Coşkun, A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1884514
“Finally, the successful prenatal management of the ongoing fourth pregnancy represents the optimal clinical translation of our molecular fi ndings (5, 19).”
InfluentialBusacca, M., Canioni, E., & Brugnoni, R. (2026) · Genes · doi:10.3390/genes17091073
Metadata
- Authors
- Miranda, M. C. D., Oliveira, A. C. M. D., Soares, G. J., Batatinha, J. A. P., Latronico, A. C., Mendonca, B. B., & Bachega, T. A. S. S.
- Affiliations
- Laboratório de Hormônios e Genética Molecular - LIM/42, Unidade de Desenvolvimento, Disciplina de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo
- Universidade de São Paulo (BR)
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2026-04-02
- Volume
- 17
- Pages
- 1770274-1770274
- ISSN
- 1664-2392 (ISSN-L)
- PMC
- PMC13083008
- OpenAlex
- W7147679433
- Semantic Scholar
- 162e5f73df44c76feec811245bdbd5090808f0b1
- Cited by
- 2
- References
- 91
- Citations by year
- 2026: 2
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/, 23/11168-1, 88887, 19/26780-9)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88887)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- 21-hydroxylase deficiency, congenital adrenal hyperplasia, CYP21A2, long-read sequencing, multiplex ligation-dependent probe amplification, allele-specific PCR, structural rearrangement, newborn screening, salt-wasting phenotype, genetic counseling
- MeSH terms
- Adrenal Hyperplasia, Congenital, Humans, Steroid 21-Hydroxylase, Genomics, Molecular Diagnostic Techniques, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques. https://app.cochat.ai/papers/10.3389/fendo.2026.1770274
- The paper
- Miranda, M. C. D., Oliveira, A. C. M. D., Soares, G. J., Batatinha, J. A. P., Latronico, A. C., Mendonca, B. B., & Bachega, T. A. S. S. (2026). Evolution of molecular diagnostic strategies for 21-hydroxylase deficiency: from classical methods to advanced genomic techniques. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1770274
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.